RONALDO ADIB KAIRALLA
Projetos de Pesquisa
Unidades Organizacionais
Departamento de Cardio-Pneumologia, Faculdade de Medicina - Docente
LIM/09 - Laboratório de Pneumologia, Hospital das Clínicas, Faculdade de Medicina
LIM/09 - Laboratório de Pneumologia, Hospital das Clínicas, Faculdade de Medicina
9 resultados
Resultados de Busca
Agora exibindo 1 - 9 de 9
conferenceObject Association Of Sarcoidosis, Monoclonal Gammopathy Of Undetermined Significance And Cardiac Amyloidosis: A Case Report(2017) AMARAL, A. F.; OLIVEIRA, M. R.; ARIMURA, F. E.; NASCIMENTO, E. C. T.; BERNARDI, F. C.; FERNANDES, F.; CARVALHO, C. R. R.; KAIRALLA, R. A.; BALDI, B. G.conferenceObject Sarcoidosis And Concomitant Pheochromocytoma - Case Report(2017) ATHAYDE, R. B. De; OLIVEIRA FILHO, J. B.; PILOTO, B. M.; TARTAGLIA, R. S.; MIRANDA, R. R.; COSTA, A. N.; ARIMURA, F. E.; KAIRALLA, R.- Concentration of serum vascular endothelial growth factor D and its correlation with functional and clinical variables in patients with lymphangioleiomyomatosis from a Brazilian reference centre(2017) OLIVEIRA, Martina Rodrigues; AMARAL, Alexandre Franco; ARIMURA, Fabio Eiji; FREITAS, Carolina Salim; KAIRALLA, Ronaldo Adib; CARVALHO, Carlos Roberto Ribeiro de; BALDI, Bruno Guedes
- Exercise in patients with pulmonary Langerhans cell histiocytosis: performance and mechanisms of limitation(2017) HEIDEN, Glaucia Itamaro; FREITAS, Carolina; SOBRAL, Juliana Barbosa; KAIRALLA, Ronaldo; CARVALHO, Carlos Roberto; SALGE, Joao Marcos; ALBUQUERQUE, Andre Luis; SOUZA, Rogerio; BALDI, Bruno
- Palliative care in interstitial lung disease: living well(2017) KREUTER, Michael; BENDSTRUP, Elisabeth; RUSSELL, Anne-Marie; BAJWAH, Sabrina; LINDELL, Kathleen; ADIR, Yochai; BROWN, Crystal E.; CALLIGARO, Greg; CASSIDY, Nicola; CORTE, Tamera J.; GEISSLER, Klaus; HASSAN, Azza Adel; JOHANNSON, Kerri A.; KAIRALLA, Ronaldo; KOLB, Martin; KONDOH, Yasuhiro; QUADRELLI, Sylvia; SWIGRIS, Jeff; UDWADIA, Zarir; WELLS, Athol; WIJSENBEEK, MarliesProgressive fibrotic interstitial lung diseases (ILDs) are characterised by major reductions in quality of life and survival and have similarities to certain malignancies. However, palliative care expertise is conspicuously inaccessible to many patients with ILD. Unmet patient and caregiver needs include effective pharmacological and psychosocial interventions to improve quality of life throughout the disease course, sensitive advanced care planning, and timely patient-centred end-of-life care. The incorrect perception that palliative care is synonymous with end-of-life care, with no role earlier in the course of ILD, has created a culture of neglect. Interventions that aim to improve life expectancy are often prioritised without rigorous assessment of the individual's health and psychosocial needs, thereby inadvertently reducing quality of life. As in malignant disorders, radical interventions to slow disease progression and palliative measures to improve quality of life should both be prioritised. Efficient patient-centred models of palliative care must be validated, taking into account religious and cultural differences, as well as variability of resources. Effective implementation of palliative care for ILD will require multidisciplinary participation from clinicians, specialist nurses, psychologists, social workers, and, in some countries, non-governmental faith and community-based organisations with access to palliative care expertise.
conferenceObject Sarcoid-Like Pulmonary Reaction Due To Chronic Lymphocitic Leukaemia(2017) KAWASSAKI, A. M.; BALDI, B. G.; AMARAL, A. F.; PEREIRA, D. A. S.; LIMA, L. G. C. A.; FREITAS, C. S. G.; CARVALHO, C. R. R.; KAIRALLA, R. A.- Pulmonary hypertension in lymphangioleiomyomatosis: prevalence, severity and the role of carbon monoxide diffusion capacity as a screening method(2017) FREITAS, Carolina S. G.; BALDI, Bruno G.; JARDIM, Carlos; ARAUJO, Mariana S.; SOBRAL, Juliana Barbosa; HEIDEN, Glaucia I.; KAIRALLA, Ronaldo A.; SOUZA, Rogerio; CARVALHO, Carlos R. R.Background: Lymphangioleiomyomatosis (LAM) is included within group 5 of the current PH classification (unclear multifactorial mechanisms). However, data regarding the occurrence of PH in LAM are scarce. The aims of the study were to describe the prevalence and characteristics of PH in a large cohort of LAM patients with different levels of severity, and to evaluate the role of echocardiography and carbon monoxide diffusion capacity (DLCO) as screening methods for PH in LAM. Methods: One hundred five LAM patients underwent transthoracic echocardiography, pulmonary function tests (PFTs) and 6-min walk test (6MWT). Patients with a suspicion of PH on echocardiography, defined by the presence of estimated systolic pulmonary artery pressure (PAP) over 35 mmHg or PFT showing DLco below 40% of the predicted value, underwent right heart catheterisation to confirm the diagnosis of PH. Results: Eight patients (7.6%) had PH confirmed on right heart catheterisation, six patients (5.7%) had a pre-capillary pattern and two patients (1.9%) had a post-capillary profile. Only one patient (1%) had mean PAP over 35 mmHg. Patients with PH had lower FEV1 and DLCO in PFTs and greater oxygen desaturation and dyspnea intensity during 6MWT compared with those without PH. In 63% of the patients with confirmed PH, the right heart catheterisation was performed based only on DLCO result. Conclusions: The prevalence of PH is low in LAM patients. Pulmonary hypertension in LAM is typically mild and significantly associated with pulmonary parenchymal involvement. Carbon monoxide diffusion capacity significantly improved the identification of PH in LAM patients.
conferenceObject Analysis Of Sarcoidosis Cases Followed At University Of Sao Paulo Medical School Of Brazil(2017) VARGAS, L. Paez; MIRANDA, R. R.; ARIMURA, F. E.; AMARAL, A. F.; OLIVEIRA, M. R.; KAIRALLA, R. A.; CARVALHO, C. R. R.; BALDI, B. G.bookPart Doenças intersticiais(2017) SANTANA, Alfredo Nicodemos da Cruz; KAWANO-DOURADO, Letícia; KAIRALLA, Ronaldo Adib